ACE and coronary artery disorder: Of patients with known CAD, 1275 (73%) received treatment with ß-blockers, 1254 (72%) with ACE or angiotensin receptor inhibitors, 1289 (74%) with statins and 1351 (78%) with antiplatelet inhibition.